Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Onconetix, Inc. (ONCO)

NASDAQ

$1.02

$+0.11

(+15.16%)

After-Hours

Onconetix, Inc. (ONCO) Live Price Chart

Last updated: ⁦2026-09-04 21:42:00⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Onconetix, Inc. (ONCO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.02, with a market capitalisation of $2.95M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.59 to $209.50. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.95M
Open	$0.74
Day's High	$90,950.00
Day's Low	$0.59
Previous Close	$0.74
Volume	3.22M
Average Volume	--
P/E Ratio	--
52-Week High	$209.50
52-Week Low	$0.59
Dividend Yield	--
Earnings Date	--

Onconetix, Inc. (ONCO) After-Hours Stock Price

Onconetix, Inc. (ONCO) is trading at $0.86 in after-hours trading as of 2026-09-04 21:41:00, up 16.51% ($0.12) from the regular-session close of $0.74.

After-hours trading shows how investors are pricing ONCO after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.

Onconetix, Inc. (ONCO) 7-Day Stock Price Change

Over the past seven days, Onconetix, Inc. (ONCO) moved from $0.60 to $1.02, representing a gain of 70.17% ($0.42).

The stock traded between $0.70 and $1.04 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 1.02 million shares, up versus the previous seven-day period, indicating higher trading activity.

ONCO 52-Week Price Position

Position in Range: 0.2%

52W Low$0.59

52W High$209.50

ONCO is currently trading at $1.02, placing it 0.2% of the way from its 52-week low of $0.59 to its 52-week high of $209.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Onconetix, Inc. (ONCO)?

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.

Onconetix, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	2
Exchange	NASDAQ
Company Website	https://www.onconetix.com

How to Buy Onconetix, Inc. (ONCO) Stock on MEXC

Eligible investors can buy real shares of Onconetix, Inc. (ONCO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ONCO and Place Your Order

Open the RealStocks trading page and search for ONCO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Onconetix, Inc. (ONCO) stock price today?

Onconetix, Inc. (ONCO) is currently trading at $ 1.02, up 38.16% ($0.28) from the previous close of $ 0.74. Intraday prices update in real time during regular trading hours.

2.Is ONCO stock going up or down today?

As of 2026-09-04 21:41:00, ONCO is trading at $ 1.02, up 38.16% ($0.28) from its previous close of $ 0.74. The stock has traded between $ 0.59 and $ 90,950.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is ONCO pre-market price?

As of 2026-09-04 21:41:00, ONCO is trading at $ 0.72 in pre-market trading, down 2.71% ($0.02) from the previous close of $ 0.74. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ONCO after-hours price?

As of 2026-09-04 21:41:00, ONCO is trading at $ 0.86 in after-hours trading, up 16.51% ($0.12) from the regular-session close of $ 0.74. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ONCO stock trading now?

ONCO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ONCO sit relative to its 52-week high and low?

Over the past 52 weeks, ONCO has traded between a low of $ 0.59 and a high of $ 209.50. At $ 1.02, the stock is positioned 0.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Onconetix, Inc. in?

Onconetix, Inc. (ONCO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Onconetix, Inc.'s market capitalisation and where is it listed?

Onconetix, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 2.95M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ONCO valued in terms of P/E ratio and EPS?

ONCO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.33. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Onconetix, Inc. pay a dividend?

Onconetix, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.